Document:

<PAGE>

                                                                   EXHIBIT 10.25

[CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE
CONFIDENTIAL PORTIONS HAVE BEEN REDACTED AND ARE DENOTED BY A DOUBLE ASTERISK
(**). THE CONFIDENTIAL PORTIONS HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.]

                                LICENSE AGREEMENT
                                -----------------

           This License Agreement, (hereinafter referred to as the "AGREEMENT")
effective as of the 7th day of November, 2001 (hereinafter referred to as
"EFFECTIVE DATE"), is by and between Becton Dickinson and Company and its
affiliates, having an address at 1 Becton Drive, Franklin Lakes, New Jersey
07417-1880 (hereinafter referred to as "BD"), and Cell Robotics International,
Inc., and its entity affiliates, having a place of business at 2715 Broadbent
Parkway, Albuquerque, New Mexico 87107 (hereinafter referred to as "CR").

                                   WITNESSETH
                                   ----------

           **.

         WHEREAS, CR desires to obtain from BD an exclusive sublicense to U.S.
Patent No. 5,165,418 and BD is willing to grant such a license to CR.

           NOW, THEREFORE, in consideration of the premises and the mutual
promises and covenants herein contained, it is agreed by and between the parties
hereto as follows:

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 2 of 15

ARTICLE I - DEFINITIONS
-----------------------

         1. **.

         2. "BD" as used herein shall mean Becton Dickinson and Company and any
entity which at any time during the life of this AGREEMENT directly or
indirectly, through one or more intermediaries, controls Becton Dickinson and
Company, is controlled by Becton Dickinson and Company, or is under common
control of Becton Dickinson and Company, (including subsidiaries of Becton
Dickinson and Company) and another entity, or is controlled by an entity that
controls Becton Dickinson and Company.

         3. "CR" as used herein shall mean Cell Robotics International, Inc. and
any entity which at any time during the life of this AGREEMENT directly or
indirectly, through one or more intermediaries, controls Cell Robotics
International, Inc., is controlled by Cell Robotics International, Inc., or is
under common control of Cell Robotics International, Inc., (including
subsidiaries of Cell Robotics International, Inc.) and another entity, or is
controlled by an entity that controls Cell Robotics International, Inc.

         4. "LICENSED PATENT" as used herein shall mean U.S. Patent No.
5,165,418.

         5. "VALID CLAIM" as used herein shall mean a claim of the LICENSED
PATENT so long as such claim shall not have been disclaimed by BD or shall not
have been held invalid or not infringed by CR in an unappealed or unappealable
decision rendered by a tribunal of competent jurisdiction.

         6. **.
<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 3 of 15

         7. "PRODUCT(S)" as used herein shall mean any product, device,
instrument, kit or component thereof which fall within the LICENSED FIELD, the
making, using, imparting, offering for sale or selling of which would, in the
absence of the license granted hereunder, infringe, contribute to the
infringement of, or induce the infringement of any VALID CLAIM of the LICENSED
PATENT.

         8. "NET SALES" as used herein shall mean, unless otherwise provided,
the invoice price at which the PRODUCT is sold by CR, to a purchaser other than
CR, either individually or as part of a kit, less returns, allowances or
credits, rebates, excise, sales, use or value-added taxes, delivery charges
billed on the invoice to the purchaser, cash and trade discounts allowed, import
duty, and commissions to agents other than employees of CR.

ARTICLE II - GRANT
------------------

         1. Subject to the terms and conditions of this AGREEMENT, BD hereby
grants to CR an exclusive, sublicense to import, make, have made for its own use
and sale, use, offer to sell, offered to sell, sold and sell PRODUCT covered by
a VALID CLAIM of the LICENSED PATENT in the United States of America, without
the right to grant sublicenses.

ARTICLE III - PAYMENTS
----------------------

         1. **.

         2. **.

         3. **.

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 4 of 15

         4. Royalties are payable by CR based solely on PRODUCT(S) sold by CR,
on a country-by-country basis, until the last to expire of the LICENSED PATENT.

         5. At the expiration of the period set forth in Paragraph 4 of this
ARTICLE, CR shall have a completely paid-up, royalty-free right and license to
subsequently make, have made, use and sell the PRODUCT(S) and shall have no
further obligations to BD.

         6. **.

         7.  (A) **.

             (B) Nothing in this Agreement shall impose upon CR the obligation
to create, continue or maximize sales of the PRODUCT(S) or prevent CR from
making, using or selling or causing to be made, have made, used or sold, any
place in the world, products competitive in nature to PRODUCT(S). Nothing herein
contained shall in any way limit CR's free and exclusive right to determine in
its discretion the timing or manner of marketing, manufacturing or advertising
the PRODUCT(S).

         8. If CR does not pay the minimum annual royalty at the time such
minimum is payable, BD, at its option, may convert this AGREEMENT to a
non-exclusive license, upon written notice to CR. CR shall have ninety (90) days
after receiving such notice to make up any deficiencies in its payments in order
to maintain its exclusive licensee status.

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 5 of 15

ARTICLE IV - REPRESENTATIONS AND WARRANTIES
-------------------------------------------

         1. BD represents and warrants that it has the right to grant the
sublicense as set forth in this Agreement and is able to enter into this
Agreement and become bound by the terms hereof.

         2. BD represents and warrants that, to the best of its knowledge, no
third party has any rights in conflict.

         3. BD represents and warrants that it is under no obligation to any
third party that would interfere with their representations or obligations under
this AGREEMENT.

ARTICLE V - BOOKS OF ACCOUNT AND REPORTS
----------------------------------------

         1. CR agrees to keep complete and accurate records of its sales of the
PRODUCT(S) sold and all data necessary for the computation of payments to be
made to BD hereunder. However, CR shall have no duty of trust or other fiduciary
relationship with BD regarding the maintenance of the books of account or the
calculation and reporting of royalties.

         2. Payments under ARTICLE III, when due, shall be made on or before the
last business day of May, August, November and February of each year for the
sales of the PRODUCT(S) sold by CR during the preceding quarterly periods ending
on the last day of March, June, September and December, respectively. Such
payments to BD shall be accompanied by a statement showing the total NET SALES
of the PRODUCT(S) sold by CR, the amount of any credit taken and such other
particulars as are necessary for an account of the payments to be made pursuant
to this Agreement. Payment of the amount due shall accompany such statement,
which shall be deemed to be true and correct unless objected to and audited in
accordance with Paragraph 4 of this ARTICLE.

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 6 of 15

         3.  (A) To the extent sales requiring a royalty payment may have been
made by CR in a country other than the United States, such royalty payments
shall be made by CR in United States dollars on the basis of conversion, from
the currency of such other country by converting the royalty in the currency of
the country in which the sales were made at the exchange rate for United States
Dollars prevailing at the close of the last business day of the calendar quarter
for which sales occurred and royalties are being calculated as published the
following day in the Wall Street Journal and with respect to those countries for
which rates are not published, the exchange rate fixed for such date by the
appropriate United States governmental agency.

             (B) The foregoing is subject to the right of CR to make payment of
royalties in any country where the currency is blocked and where legal
conversion of the currency billed cannot be made into United States dollars by
depositing such royalty payments in BD's name in a bank designated by BD within
such country.

         4. BD, at its own expense, shall have the right for a period of three
(3) years after receiving any report from CR to nominate an independent
Certified Public Accountant, acceptable to CR which acceptance shall not be
unreasonably withheld, who shall have access to CR's records during reasonable
business hours for the purpose of verifying the payments made under this
Agreement, but this right may not be exercised more than once in any calendar
year, and the Accountant shall disclose to BD information limited only to the
accuracy of the payment report and the payments made in accordance with this
Agreement.

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 7 of 15

ARTICLE VI - PATENT LITIGATION
------------------------------

         1.  (A) In the event either party hereto receives notice of alleged
infringement of any of the LICENSED PATENT, it shall promptly notify the other
party in writing of such infringement. BD shall have the right, but not the
obligation, to bring suit and to control the conduct thereof against the alleged
infringer, and to join CR as a party to such suit, in which event BD shall hold
CR free, clear and harmless from any and all costs and expenses of such
litigation, including attorneys' fees. In the event BD exercises the right to
bring suit herein conferred, it shall have the right to retain all damages
recovered.

             (B) If BD does not bring suit against said infringer, as herein
provided, within one hundred twenty (120) days after receipt of such notice, CR
shall have the right, but shall not be obligated, to bring suit for such alleged
infringement, and to join BD as a party to such suit only if a court of
competent jurisdiction determines BD is a necessary party to such suit, in which
event CR shall hold BD free, clear and harmless from any and all costs and
expenses of such litigation, including attorneys' fees. In the event CR
exercises the right to bring suit for such alleged infringement, it shall have
the right to retain all damages recovered.

             (C) Each party shall always have the right to be represented by
counsel of its own selection and at its own expense in any suit instituted by
the other for infringement, under the terms hereof. Either party has the right,
within ninety (90) days of the filing of the original complaint, to join in, but
not control, any infringement suit brought by the other party and shall share
equally in the cost and expenses of such litigation, including attorneys' fees,
and any sums recovered.

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 8 of 15

ARTICLE VII - TRANSFERABILITY OF RIGHTS AND OBLIGATIONS
-------------------------------------------------------

         1. This AGREEMENT and the license granted under it may not be assigned,
transferred or sold by CR, without the express prior written consent of BD,
which shall not be unreasonably withheld. If CR assigns this AGREEMENT, the
assignee shall agree in writing, which shall be provided to BD, to assume all
obligations of CR created by this AGREEMENT.

         2. BD may freely assign this AGREEMENT in whole or in any part.

         3. This AGREEMENT shall be binding upon and inure to the benefit of the
successor and assigns or the parties hereto to which this AGREEMENT relates.

ARTICLE VIII - **
-----------------

         1. **.

         2. **.

ARTICLE IX - DURATION AND TERMINATION
-------------------------------------

         1. Unless sooner terminated as herein provided in Paragraph 2 of this
ARTICLE, this Agreement shall continue in effect until the expiration of the
LICENSED PATENT.

         2. BD shall have the right to terminate this AGREEMENT if CR commits a
material breach of an obligation under this AGREEMENT, including the failure to
make timely payments hereunder, and continues in default for more than sixty
(60) days after receiving written notice from BD of such default, such
termination to be effective immediately upon further written notice to CR after
such sixty (60) day period. If such material breach by CR occurs, all payments
of any kind under this AGREEMENT shall be accelerated and shall become
immediately due and payable by CR, and CR consents to the entry of judgment in
the amount of such payments becoming immediately due.

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 9 of 15

         3. In the event that CR shall be adjudicated bankrupt, go into
liquidation, receivership or trusteeship, make a composition with its creditors
or enter into any similar proceeding of the same nature, then BD shall have the
right without liability therefore to terminate this AGREEMENT forthwith by
notice in writing to CR. Nothing herein shall limit any other remedies to which
BD may be entitled under law or equity.

ARTICLE X - DISCLAIMER, AND HOLD HARMLESS
-----------------------------------------

         1. It is understood and agreed by and between the parties hereto that
nothing contained in this AGREEMENT shall constitute or be construed to
constitute any undertaking, representation, suggestion, inducement, warranty,
assurance or guarantee whatsoever by either party in connection with PRODUCT(S)
or any component, product, material, service, process or apparatus with respect
to safety, quality, yield, production, cost, profit, saleability, licensability,
demand, utility, performance, availability of raw materials, accident or injury
to person or property.

         2. CR expressly indemnifies and holds BD, its affiliates, successors
and assigns and its officers, directors and employees harmless from and against
any and all claims, liabilities, damages, costs, expenses, and/or actions of any
kind whatsoever relating to product liability claims which arise from or are
connected with the manufacture, use, lease, importation, offer for sale, sale,
or other disposition of PRODUCT(S) under the LICENSED PATENT.

ARTICLE XI - MISCELLANEOUS
--------------------------

         1. Any notice or other communication required or permitted by this
Agreement shall be deemed to have been validly delivered on the date mailed if
the same shall be mailed by registered or certified mail, postage prepaid,
return receipt requested, or faxed with confirmation, addressed as follows:

           To BD:              Becton, Dickinson and Company
                               Preanalytical Solutions
                               1 Becton Drive
                               Franklin Lakes, NJ  07417-1880
                               Attention:  President
                               Tel. No.:  (201) 847-4508
                               Fax No.:  (201) 847-4867

           With copy to:       Becton, Dickinson and Company
                               1 Becton Drive
                               Franklin Lakes, NJ 07417-1880
                               Attention:  Chief Intellectual Property Counsel
                               Tel. No.:  (201) 847-7116
                               Fax No.:  (201) 848-9228

           To CR:              Cell Robotics, Inc.
                               2715 Broadbent Parkway
                               Alburquerque, New Mexico
                               Attention:  Ronald K. Lohrding, Ph.D.
                               Tel. No.:  505-343-1131 Ext. 106
                               Fax No.:  505-344-8112

           2.     All royalty payments shall be addressed as follows:

           To BD:              Becton, Dickinson and Company
                               1 Becton Drive
                               Franklin Lakes, NJ 07417-1880
                               Att:  Controller, BD Preanalytical Solutions
<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 11 of 15

         3. Nothing herein contained shall be construed to place the parties in
the relationship of partners or joint venturers or principal and agent or create
any entity or association, and neither party shall have the power to obligate or
bind the other in any manner whatsoever.

         4. CR shall not use the name of BD or any adaptation thereof in any
advertising, promotion, sales literature or packaging in a manner which would
constitute an expressed or implied endorsement for any commercial product
without the prior written consent of BD.

         5. Nothing herein contained shall be construed to grant to CR any
license or rights in any other of BD's intellectual property.

         6. Neither CR nor BD shall be responsible for and the terms of this
AGREEMENT shall be inapplicable to any default or delays which are due to cause
beyond CR's or BD's control, including but without limitation acts of God or of
the public enemy, acts or any order of a government, fires, floods, or other
natural disasters, embargoes, accidents, explosions, strikes, or other labor
disturbances (regardless of the reasonableness of the demands of labor),
shortages of fuel, power or raw materials, inability to obtain or delays of
transportation facilities, incidents of war, or other events causing the
inability of CR or BD, acting in good faith with due diligence, to perform its
obligations under this AGREEMENT.

         7. This Agreement constitutes the entire agreement between the parties
hereto with respect to the subject matter hereof, and no modification of this
Agreement shall be effective unless it is in writing and is signed by a duly
authorized representative of each party. There are no understandings,
representations or warranties except as herein expressly set forth.

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 12 of 15

         8. The failure or delay of a party hereto to enforce any of its rights
under this Agreement shall not be deemed to be a continuing waiver or a
modification by such party of any of its rights under this Agreement, and a
party may, within the time provided by the applicable law, commence appropriate
legal proceedings to enforce any or all of its rights under this Agreement. Any
failure to enforce or delay in enforcement shall not constitute a defense.

         9. Neither party shall originate any publicity, news release or public
announcement, written or oral, whether to the public, press or otherwise,
relating to this Agreement, to any amendment hereto or performance hereunder,
without approval of the other party which approval shall not be unreasonably
held, save only such announcement as in the advice of counsel to the party
making such announcement is required by law to be made. In the event CR is
required by law to disclose this AGREEMENT, CR shall notify BD in writing within
ten (10) days before making such disclosure and CR shall make every reasonable
effort to only disclose the redacted version of the AGREEMENT attached hereto in
Appendix A.

         10. This AGREEMENT shall be binding upon and inure to the benefit of
the successor and assigns of BD and CR to which this AGREEMENT relates.

         11. Should any part or provision of this Agreement be held
unenforceable or in conflict with the law of any jurisdiction, the validity of
the remaining part or provisions shall not be affected by such holdings.

         12. BD hereby releases CR from any alleged infringement of the LICENSED
PATENT prior to and including the EFFECTIVE DATE of this AGREEMENT, and more
particularly, BD releases CR and its customers from any and all liability
resulting from the manufacture, importation, use, offer for sale, leasing,
transferring, exporting, importing, sale or otherwise disposing of any PRODUCT
which may have infringed the LICENSED PATENT prior to and including the
EFFECTIVE DATE of this AGREEMENT and whose continued use would infringe the
LICENSED PATENT subsequent to the EFFECTIVE DATE of this AGREEMENT.

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 13 of 15

         13. This Agreement shall be construed, interpreted and applied in
accordance with and governed by the laws of the State of New Jersey, United
States of America and the parties hereby submit to the jurisdiction of the
courts of that State.

         IN WITNESS WHEREOF, BD and CR have caused this Agreement to be duly
executed in duplicate originals as of the date first hereinabove written.

Cell Robotics International, Inc.           Becton, Dickinson and Company

By:   /s/ Ronald K. Lohrding                By: /s/ Richard O. Brajer
      ---------------------------               --------------------------------
      Ronald K. Lohrding, Ph.D                  Richard O. Brajer
      President and CEO                         President
                                                BD Clinical Laboratory Solutions

Date: 12/17/01                              Date: 1/3/02
      ---------------------------                 ------------------------------

<PAGE>
CONFIDENTIAL
LICENSE AGREEMENT
Page 14 of 15

                                   APPENDIX A

**PAGES 1 THROUGH 15 REDACTED<PAGE>

Exhibit 10.10

                              EMPLOYMENT AGREEMENT
                              --------------------

         THIS EMPLOYMENT AGREEMENT ("Agreement") is entered into on June 30,
2001 to be effective as of July 1, 2001 between VIRTGAME.COM CORP., a Delaware
corporation ("Employer"), and BRUCE MERATI ("Executive").

                                  R E C I T A L
                                  -------------

         Employer wishes to employ Executive, and Executive agrees to serve, as
Chief Operating Officer and Chief Financial Officer of Employer, subject to the
terms and conditions set forth below.

                                A G R E E M E N T
                                -----------------
         It is agreed as follows:

         1. TERM OF EMPLOYMENT. Employer hereby employs Executive, and Executive
hereby accepts employment with Employer, for a period of two (2) years
terminating July 1, 2003 ("Employment Period"); provided that this Agreement
shall be automatically renewed for successive two (2) year terms unless either
party elects not to renew this Agreement by delivering written notice of its
election to the other party no later than ninety (90) days prior to the end of
the current term. Notwithstanding anything in this Section 1 to the contrary,
this Agreement may be terminated at any time in accordance with Section 6.

         2. DUTIES OF EMPLOYEE. Executive shall serve in the capacity as Chief
Operating Officer and Chief Financial Officer of Employer at Employer's office
in San Diego, California, or, should the Company open a Las Vegas, at such Las
Vegas office, pursuant to the request of the Employer's Chief Executive Officer
or Board of Directors. Executive accepts such employment and agrees to perform
services for the Company. Executive shall perform such other services and duties
as may from time to time be assigned to Executive by Employer's Chief Executive
Officer or Board of Directors provided that such other services and duties are
not inconsistent with any other term of this Agreement. Except during vacation
periods or in accordance with Employer's personnel policies covering Executive
leaves and reasonable periods of illness or other incapacitation, Executive
shall devote his services to Employer's business and interests in a manner
consistent with Executive's title and office and Employer's needs for his
services. Executive shall perform the duties of Executive's office and those
assigned to Executive by the Employer's Chief Executive Officer or Board of
Directors with fidelity, to the best of Executive's ability, and in the best
interest of Employer.

         3. COMPENSATION OF EMPLOYEE.

                  3.1 BASE COMPENSATION. As compensation for Executive's
services hereunder, Executive shall receive a base salary ("Base Salary"), which
will be at least One Hundred Twenty Five Thousand Dollars ($125,000) per year,
payable in equal bi-monthly installments, or a ratable portion thereof for
periods of less than one-half month. The term Base Salary as utilized in this
Agreement shall refer to Base Salary as so increased. Any increase in Base

<PAGE>

Salary shall not serve to limit or reduce any other obligation to Executive
under this Agreement. Base Salary shall not be reduced at any time during the
Employment Period.

                  3.2 BONUS COMPENSATION.

                           3.2.1 CASH INCENTIVE BONUSES. As additional
compensation for Executive's services hereunder, Executive shall be entitled to
a cash bonus of $30,000 for the first two million dollar investment made into
the Company and 10% for each software licensing agreement the Company makes - up
to $25,000 per agreement - with any of the following gaming companies, Park
Place Entertainment, MGM Mirage, Mandalay Resort Group, Desert Inn or Harrah's
Entertainment. Executive will receive the 10% bonuses - up to $25,000 per
agreement - only when the Company collects its revenues from these contracts.

                           3.2.2 AUTOMOBILE ALLOWANCE. The Company shall pay
Executive an automobile allowance of $500 per month. Said amount shall be
payable to Executive no later than the tenth day of each month.

                           3.2.3 STOCK OPTIONS PLAN. The Company shall issue
stock options to Executive pursuant to the Company's Stock Option Plan or any
successor thereto. Upon execution of this agreement, Employer shall issue to
Executive an option to purchase The number of stock options issued to the
Executive in 2001 upon execution of this agreement will be one million shares of
common stock priced at with a strike price of $0.25 per share, exercisable for a
period of 5 years (2001 Options). 500,000 of the 2001 Options shall vest upon
execution of this agreement and be exercisable immediately, but Executive agrees
not to sell these options for a period of one year from the date of this
agreement. The remaining 500,000 options of the 2001 Options shall vest and be
exercisable one year from the date of this agreement, provided this agreement
has not been terminated in accord with paragraph 6. In the event of the Company
carrying out a "rights offering" of its stock, the Company shall issue Executive
additional stock options as an anti-dilution measure to provide the same
percentage as prior to the offering.

                           3.2.4 HEALTH INSURANCE PLAN. The Company shall
provide Executive and his immediate family members with comprehensive health
insurance, which shall cover medical, dental and vision.

         4. EXPENSE REIMBURSEMENTS. Executive shall be reimbursed for reasonable
and actual out-of-pocket expenses incurred by Executive in performance of
Executive's duties and responsibilities hereunder in accordance with Employer's
established personnel policy covering Executive officer expense reimbursements,
as such policy may be amended, revised or otherwise changed from time to time.
Executive shall furnish proper vouchers and expense reports and shall be
reimbursed only for those expenses, which shall be reimbursable.

         5. VACATION AND SICK DAYS. Executive shall be entitled to fifteen (15)
days vacation time each year without loss of compensation. In the event that

                                     - 2 -
<PAGE>

Executive is unable for any reason to take the total amount of vacation time
authorized herein during any year, any unused vacation time shall carry over
from year to year. Executive shall also be entitled to leaves for illness or
other incapacitation.

         6. TERMINATION.

                  6.1 TERMINATION BY EMPLOYER FOR CAUSE. Employer may terminate
this Agreement and Executive's employment hereunder for Cause (as defined
herein) any time effective upon written notice to Executive. As used herein, the
term "Cause" shall mean:

                           6.1.1 Habitual neglect in the performance of
Executive's material duties as set forth in Section 2 which continues
uncorrected for a period of thirty (30) days after written notice thereof by
Employer to Executive;

                           6.1.2 Gross negligence involving misfeasance or
nonfeasance by Executive in the performance of Executive's material duties as
set forth in Section 2 which continues uncorrected for a period of thirty (30)
days after written notice thereof by Employer to Executive;

                           6.1.3 Insubordination in the form of the unexcused
or unexcusable failure to carry out the written instructions of the Board of
Directors of Employer, which continues uncorrected for a period of thirty (30)
days after written notice thereof by Employer to Executive. Any claimed
insubordination will be excusable on the basis that the Board of Directors'
instructions propose a violation of law or actions beyond the control of
Executive.

Upon termination for Cause, Executive will as soon as practicable be paid: (A)
Executive's Base Salary at the usual rate through the date of termination
specified in such notice; and (B) any amounts which Executive has earned under
any Employer benefit plan in accordance with the terms of such plan through the
date of termination.

                  6.2 TERMINATION WITHOUT CAUSE. Either Executive or Employer
may terminate this Agreement and Executive's employment without Cause on thirty
days' prior written notice. In the event of termination pursuant to this Section
6.2, compensation will be paid and benefits will be provided to Executive as
follows:

                           6.2.1 If the termination is by Executive without Good
Reason (as defined in Section 6.4 below), Executive will as soon as practicable
be paid: (A) Executive's Base Salary at the usual rate through the date of
termination specified in such notice (but not to exceed thirty days from the
date of such notice); and (B) any amounts which Executive has earned under any
Employer benefit plan in accordance with the terms of such plan through the date
of termination; or

                           6.2.2 If the termination is by Employer, and except
as provided under Section 6.5, Employer will as soon as practicable pay
Executive: (A) a lump sum payment equal to the pro rata portion of Executive's
Base Salary for sixty days following the date of termination; (B) the
proportionate amount of any unpaid bonus or incentive deemed earned for the year
in which the termination takes place; (C) a lump sum payment equal to any
retirements benefits lost as a result of not having been employed for the

                                     - 3 -
<PAGE>

remaining term of the Agreement; and (D) a reasonable amount of outplacement
assistance (not to exceed fifteen percent of Executive's Base Salary).

                           6.2.3 Without limiting the generality of the
foregoing, termination on account of Executive's retirement, whether voluntary
or mandatory, and whether normal or early approved, will be considered a
termination by Executive other than for Good Reason.

                  6.3 TERMINATION UPON DEATH OR DISABILITY. This Agreement and
Executive's employment hereunder shall terminate upon Executive's death or
Disability (as defined herein). For this purpose, "Disability" means incapacity,
whether by reason of physical or mental illness or disability, which prevents
Executive from substantially performing Executive's material duties as set forth
in Section 2 for six (6) months. Upon termination for death, and unless Employer
shall have in force a disability insurance policy providing for benefits in an
amount at least equal thereto, upon termination for Disability, Employer shall
continue to pay the Executive's Base Salary to the surviving spouse of Executive
(or if there is none to Executive's estate) in the case of death and to
Executive or Executive's court appointed conservator in the case of Disability
for six (6) months thereafter. Termination for death shall become effective upon
the occurrence of such event and termination for Disability shall become
effective upon written notice by Employer to Executive.

                  6.4 TERMINATION FOR GOOD REASON. Executive may terminate this
Agreement and Executive's employment upon thirty days' prior written notice to
Employer for Good Reason, which notice must be given within sixty days of the
occurrence of an event constituting Good Reason or will be deemed waived. For
purposes of this Agreement, "Good Reason" means: (i) a reduction by Employer in
Executive's Base Salary to a rate less than the initial Base Salary rate set
forth in this Agreement; (ii) a change in the eligibility requirements or
performance criteria under any employee benefit plan or incentive compensation
arrangement under which Executive is covered on the effective date of this
Agreement, and which materially adversely affects Executive; (iii) the
assignment to Executive of any duties or responsibilities which are materially
inconsistent with Executive's status or position as a member of Employer's
executive management group; or (iv) Executive's good faith and reasonable
determination, after consultation with nationally-recognized counsel, that
Executive is being unduly pressured or required by the Board or a senior
Executive of Employer to directly or indirectly engage in criminal activity. In
the event of termination for Good Reason pursuant to this Section 6.4., Employer
will pay Executive the amounts and provide the benefits described under Section
6.2.2.

                  6.5 TERMINATION FOR GOOD REASON FOLLOWING A CHANGE IN CONTROL.

                           6.5.1 DEFINITION OF CHANGE IN CONTROL. For purposes
of this Agreement, a "Change of Control" shall mean the first to occur of the
following:

                           (a) The acquisition by an individual, entity or group
(within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange
Act of 1934, as amended (the "Exchange Act")) after the date hereof of
beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
Exchange Act) of thirty-three percent (33%) or more of the combined voting power
of the then outstanding voting securities of Employer entitled to vote generally

                                     - 4 -
<PAGE>

in the election of directors (the "Outstanding Employer Voting Securities");
provided, however, that the following acquisitions of common stock shall not
constitute a Change of Control: (i) any acquisition by Employer, (ii) any
acquisition by any employee benefit plan (or related trust) sponsored or
maintained by Employer or any corporation controlled by Employer, or (iii) any
acquisition by any corporation pursuant to a reorganization, merger, statutory
share exchange or consolidation which would not be a Change of Control under
subsection (c) of this Section 6.5; or

                           (b) Individuals who, as of the date hereof,
constitute the Board of Directors of Employer (the "Incumbent Board") cease for
any reason to constitute at least a majority of the Board; provided, however,
that any individual becoming a director subsequent to the date hereof whose
election, or nomination for election by Employer's shareholders, was approved by
a vote of at least a majority of the directors then comprising the Incumbent
Board shall be considered as though such individual were a member of the
Incumbent Board, but excluding, for this purpose, any such individual whose
initial assumption of office occurs as a result of either an actual or
threatened election contest or other actual or threatened "solicitation" (as
such term is used in Regulation 14A promulgated under the Exchange Act) of
proxies or consents by or on behalf of a person other than the Incumbent Board;
or

                           (c) Consummation of a reorganization, merger,
statutory share exchange or consolidation, unless, following such
reorganization, merger, statutory share exchange or consolidation, (i) at least
fifty percent (50%) of the combined voting power of the then outstanding voting
securities of the corporation resulting from such reorganization, merger,
statutory share exchange or consolidation entitled to vote generally in the
election of directors is then beneficially owned, directly or indirectly, by all
or substantially all of the individuals and entities who were the beneficial
owners of the Outstanding Employer Voting Securities immediately prior to such
reorganization, merger, statutory share exchange or consolidation in
substantially the same proportions as their ownership, immediately prior to such
reorganization, merger, statutory share exchange or consolidation, (ii) no
person (excluding Employer, any employee benefit plan (or related trust) of
Employer or such corporation resulting from such reorganization, merger,
statutory share exchange or consolidation and any person beneficially owning,
immediately prior to such reorganization, merger, statutory share exchange or
consolidation, directly or indirectly, thirty-three percent (33%) or more of the
Outstanding Employer Voting Securities, as the case may be) beneficially owns,
directly or indirectly, thirty-three percent (33%) or more of the combined
voting power of the then outstanding voting securities of the corporation
resulting from such reorganization, merger, statutory share exchange or
consolidation entitled to vote generally in the election of directors and (iii)
at least a majority of the members of the board of directors of the corporation
resulting from such reorganization, merger, statutory share exchange or
consolidation were members of the Incumbent Board at the time of the execution
of the initial agreement providing for such reorganization, merger or
consolidation; or

                           (d) Consummation of (i) a complete liquidation or
dissolution of Employer or (ii) the sale or other disposition of all or
substantially all of the assets of Employer, other than to a corporation, with
respect to which following such sale or other disposition, (A) at least fifty

                                     - 5 -
<PAGE>

percent (50%) of the combined voting power of the then outstanding voting
securities of such corporation entitled to vote generally in the election of
directors is then beneficially owned, directly or indirectly, by all or
substantially all of the individuals and entities who were the beneficial
owners, respectively, of the Outstanding Employer Voting Securities immediately
prior to such sale or other disposition in substantially the same proportion as
their ownership, immediately prior to such sale or other disposition, of the
Outstanding Employer Voting Securities, (B) no person (excluding Employer and
any employee benefit plan (or related trust) of Employer or such corporation and
any person beneficially owning, immediately prior to such sale or other
disposition, directly or indirectly, thirty-three percent (33%) or more of the
Outstanding Employer Voting Securities, as the case may be) beneficially owns,
directly or indirectly, thirty-three percent (33%) or more of, respectively, the
then outstanding shares of the combined voting power of the then outstanding
voting securities of such corporation entitled to vote generally in the election
of directors and (C) at least a majority of the members of the board of
directors of such corporation were members of the Incumbent Board at the time of
the execution of the initial agreement or action of the Board providing for such
sale or other disposition of assets of Employer.

                           6.5.2 COMPENSATION IN THE EVENT TERMINATION FOLLOWING
A CHANGE IN CONTROL. In the event Executive terminates this Agreement and
Executive's employment for Good reason following a Change in Control or Employer
terminates this Agreement without cause following Change in Control, Employer
will as soon as practicable pay Executive The amounts and provide the benefits
described under Section 6.2.2.

                  6.6 NO MITIGATION REQUIRED. Executive shall not be required to
mitigate the amount of any payments provided for in this Section 6 by seeking
other employment or otherwise, nor shall the amount of any payments provided for
in this Section 6 be reduced by any compensation earned by Executive as the
result of employment by another employer after the date of Executive's
termination by Employer, or otherwise.

                  6.7 EVENTS UPON TERMINATION. The termination of this Agreement
pursuant to Section 6 shall also result in the termination of all rights and
benefits of Executive under this Agreement except for any rights to compensation
accrued under Section 6 prior to the date of termination or rights to expense
reimbursement under Section 4.

         7. EXECUTIVE'S REPRESENTATIONS. Executive represents and warrants that
Executive is free to enter into this Agreement and to perform each of the
provisions contained herein. Executive represents and warrants that Executive is
not restricted or prohibited, contractually or otherwise, from entering into and
performing this Agreement, and that Executive's execution and performance of
this Agreement is not a violation or breach of any agreement between Executive
and any other person or entity.

         8. GENERAL PROVISIONS.

                  8.1 SEVERABLE PROVISIONS. The provisions of this Agreement are
severable, and if any one or more provisions may be determined to be judicially
unenforceable, in whole or in part, the remaining provisions shall nevertheless
be binding and enforceable.

                                     - 6 -
<PAGE>

                  8.2 ASSIGNMENT. This Agreement shall be binding upon and shall
inure to the benefit of Employer, its successors and assigns and Employer shall
require any successor or assign (whether direct or indirect, by purchase,
merger, consolidation or otherwise) to expressly assume and agree to perform
this Agreement in the same manner and to the same extent that Employer would be
required to perform if no such succession or assignment had taken place. The
term "Employer" as used herein shall include such successors and assigns. The
term "successors and assigns" as used herein shall mean a corporation or other
entity acquiring all or substantially all the assets and business of Employer
(including this Agreement) whether by operation of law or otherwise. Neither
this Agreement nor any of the rights or obligations of Executive hereunder shall
be assignable except by operation of law or the rules of descent.

                  8.3 ATTORNEYS' FEES. If any legal action arises under this
Agreement or by reason of any asserted breach of it, the prevailing party shall
be entitled to recover all costs and expenses, including reasonable attorneys'
fees, incurred in enforcing or attempting to enforce any of the terms, covenants
or conditions, including costs incurred prior to commencement of legal action,
and all costs and expenses, including reasonable attorneys' fees, incurred in
any appeal from an action brought to enforce any of the terms, covenants or
conditions.

                  8.4 NOTICES. Any notice to be given to Employer under the
terms of this Agreement shall be addressed to Employer at the address of
Employer's principal place of business, and any notice to be given to Executive
shall be addressed to Executive at his home address last shown on the records of
Employer, or at such other address as either party may hereafter designate in
writing to the other. Any notice required or permitted under this Agreement
shall be in writing and shall be deemed effective: (i) upon receipt in the event
of delivery by hand, including delivery made by private delivery or overnight
mail service where either the recipient or delivery agent executes a written
receipt or confirmation of delivery; or (ii) 72 hours after deposited in the
Swiss mail, postage prepaid.

                  8.5 WAIVER. Either party's failure to enforce any provision or
provisions of this Agreement shall not in any way be construed as a waiver of
any such provision or provisions, or prevent that party thereafter from
enforcing each and every other provision of this Agreement.

                  8.6 ENTIRE AGREEMENT; AMENDMENTS. With the exception of the
Company's Employee Manual which shall remain unaffected by this Agreement, this
Agreement supersedes any and all other agreements, either oral or in writing,
between the parties hereto with respect to the employment of Executive by
Employer and contains all of the covenants and Agreements between the parties
with respect to the employment of Executive by Employer. Each party to this
Agreement acknowledges that no representations, inducements, promises or
agreements, orally or otherwise, have been made by any party, or anyone acting
on behalf of any party, which are not embodied herein, and that no other
agreement, statement or promise not contained in this Agreement will be
effective only if it is in writing signed by the party to be charged.

                  8.7 TITLES AND HEADINGS. Titles and headings to sections of
this Agreement are for the purpose of reference only and shall in no way limit,
define or otherwise affect the interpretation or construction of such
provisions.

                                     - 7 -
<PAGE>

                  8.8 GOVERNING LAW. This Agreement shall be governed by and
construed in accordance with the laws of California.

         IN WITNESS WHEREOF, the parties have executed this Agreement as of the
day and year first above written.

                                  "EMPLOYER"

                                  VIRTGAME.COM CORP.,
                                  a Delaware corporation

                                  By:
                                      ------------------------------------------
                                      SCOTT A. WALKER
                                      Interim CEO / President and Board Member

                                      "EXECUTIVE"

                                      ------------------------------------------
                                      Bruce Merati

                                     - 8 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}]]